News
Human trials of Neuralink's brain chip to begin in UK
Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical tools using their thoughts. The firm has partnered with University College London Hospitals Trust and Newcastle Hospitals for this groundbreaking study.
Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...
News-Medical.Net on MSN3d
Centauri Therapeutics receives an additional $5.1 M from CARB-X to progress ABX-01 lead compound to first in human clinical trialsCentauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology ...
IFLScience on MSN8d
"Groundbreaking" Obesity Treatment That Turns Up The Heat On Fat Cells Passes Phase I Clinical TrialsIn what is being hailed as a “groundbreaking achievement” for Uruguay and South America, a weight loss drug has successfully ...
A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.
Tulsi Therapeutics, a biotech startup from Hyderabad, has reversed chronic liver failure in animal trials using Tulsi-28X, a ...
Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...
Losing teeth may no longer be a major concern. A drug that can regrow lost teeth is now preparing to enter human trials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback